Basic Information
Basic information for XIST-215-12aa-2
Peptide Name XIST-215-12aa-2
Genome Position chrX:73827305-73827340[-]
Species Human
Peptide Sequence MEGPCHKAYLDG
Peptide Length 12
Unique No (XIST-201-12aa,XIST-203-12aa,XIST-204-12aa-11,XIST-206-12aa-3,XIST-211-12aa,XIST-212-12aa-3,XIST-213-12aa-4,XIST-214-12aa-1,XIST-216-12aa,XIST-217-12aa-1,XIST-218-12aa-5,XIST-219-12aa-3,XIST-221-12aa-2,XIST-222-12aa-4,XIST-223-12aa-2,XIST-224-12aa,XIST-225-12aa-9,XIST-226-12aa-3,XIST-230-12aa)
Grand Average of Hydropathicity -0.65
Relative Molecular Mass 1518.67
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000229807;XIST
Transcript ID/Name ENST00000648607;XIST-215
Transcript Length 5461
Coding Ability 0.4761
DNA Sequence Corresponding to Peptide ATGGAAGGCCCCTGTCACAAAGCCTACCTAGATGGA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :